Venture capital investment in medtech grows in Q3

November 18, 2014 By Brad Perriello

Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.

Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.

"Cutting-edge innovations in medical devices, like minimally invasive surgical devices, image-guided devices, and cardiovascular and neurological therapy devices, are reshaping the medical therapeutics segment and hence provide high return investment opportunities for venture capital funds," PwC life sciences partner Greg Vlahos said in prepared remarks.

Overall VC investment in life sciences grew 6.7% to $1.6 billion but declined -2.1% in terms of volume, to 188 deals during the quarter. Life science deals accounted for 17% of VC funding in Q3, down from 19% during the same period last year, according to the MoneyTree report, compiled by PwC and the National Venture Capital Assn. using data from Thomson Reuters.

“Following the record high investments in biotech in the 2nd quarter of this year, this continued year-over-year growth is a good performance for the quarter," Vlahos said. "In the 2nd quarter, a couple of $100 million-plus mega-deals tipped the scales, including Intarcia’s $200 million round. And, with biotech still accounting for the lion’s share of new initial public offerings – 18 out of 23 IPOs in the 3rd quarter were for life sciences companies, including 13 for biotech alone – there’s reason to believe that the overall environment for biotech venture investments remains robust."

Packaging Compliance Labs expanding in Michigan
Packaging Compliance Labs, LLC (PCL) will be expanding its current operations in Kentwood, Mich. In addition to a capital investment of $2.57 million, the company will bring 27 new jobs to the area. The medical device and pharmaceutical packaging engineering and validation firm, along with its sister company, SmartStart Medical (SSM), will take on the… […]
Survey: Half of heart attack patients avoid the hospital during pandemic
The number of heart attack patients seeking urgent hospital care has dropped by more than 50% worldwide during the COVID-19 outbreak, according to a survey by the European Society of Cardiology (ESC). The survey of 3,101 healthcare professionals in 141 countries was conducted in mid-April.The findings are published in European Heart Journal — Quality of… […]
Resolution Medical hires industry veteran as CEO
Resolution Medical recently announced that it has brought on industry veteran David Blaeser as its new CEO. The Fridley, Minn.–based medical device contract manufacturing and development company noted that Blaeser has 35 years of experience leading teams at Boston Scientific, Velocimed, Nidus, Endometabolic Solutions, Libra Medical, and Zift Medical. Most recently, he was founder and CEO… […]
The George Floyd case has rocked a major U.S. medtech hub: Here’s what industry leaders think
Major medtech companies with a presence in the Minnesota have been calling for peace, unity and racial justice following the death of George Floyd in police custody and the resulting demonstrations and violence. Executives from Boston Scientific, Medtronic and the Medical Alley Association have penned open letters expressing their concerns and pledging to do better.… […]
Summit Medical produces 1 million face shields in 8 weeks
Summit Medical recently announced that it has delivered more than 1 million FDA-compliant face shields for to protect healthcare workers and returning business employees during the COVID-19 pandemic. St. Paul-based Summit Medical said it designed, engineered and manufactured the face shields in just 8 weeks, cross-training staff to assemble them and saving 65 employees’ jobs.… […]
PAVmed inks deal with Canon Virginia on ear tube manufacturing
Pavmed (NSDQ:PAVM) today announced it plans to develop and use Canon Virginia’s commercial-grade and scalable aqueous silk fibroin molding process to manufacture its DisappEAR molded pediatric ear tubes. Under terms outlined in a letter of intent, PAVmed and Canon Virginia propose to enter into two sequential agreements covering a 5-phase project culminating in the commercialization of… […]
Study finds delays in seeking stroke treatment amid COVID-19
Ischemic stroke patients are showing up to the hospital an average of 160 minutes later during the COVID-19 pandemic than during a similar timeframe in 2019, according to a new study. The delay is affecting both stroke survival and recovery, add stroke surgeons from the Society of NeuroInterventional Surgery (SNIS). The first study to confirm… […]
Performance Motion Devices touts new Juno outer loop control ICs
Performance Motion Devices announced the launch of its Juno outer loop control ICs for use in medical, industrial and military applications. The Westford, Mass.-based company’s new Juno product joins a portfolio of velocity and toque control ICs (integrated circuits) used for spindle control, centrifuge control, precision torque control and other liquid handling and laboratory automation… […]
Lille Group releases Cardiac Signals cloud-based patient monitoring software
Lille Group announced today that it launched its Cardiac Signals cloud-based software platform for healthcare professionals to monitor cardiac patients remotely. The secure platform enables cardiology practices and hospitals to manage cardiac patients remotely with ease and efficiency, which is aimed to help during a potential telehealth boom as the COVID-19 pandemic continues and onsite… […]
The secret to building a successful medtech career
In this week’s DeviceTalks Weekly podcast, Edwards Lifesciences executive Dr. Todd Brinton shares the one trait he looks for in job candidates that can trump talent and ability. Brinton, who is VP of advanced technology and chief scientific officer at Edwards Lifesciences (NYSE:EW), also offered tips on when candidates need to shift from conforming to differentiating.… […]
Medtronic is making its ‘artificial lung’ therapy available for COVID-19 treatment
Medtronic (NYSE:MDT) is temporarily modifying product indications so that health providers can use its extracorporeal membrane oxygenation (ECMO) technology to treat people with severe cases of COVID-19. ECMO could be described as a type of “artificial lung” technology that pumps blood from a person’s body to an oxygenator that provides long-term oxygen and carbon-dioxide transfer. Medtronic… […]